Phosphatase of regenerating liver-1 (PRL-1) is a novel target for potentially treating cancer metastases. Although its specific biochemical role in these processes has yet to be delineated, considerable evidence suggests the phosphatase activity of PRL-1 is required for promoting cancer and metastasis. PRL-1 belongs to the protein tyrosine phosphatase (PTPase) family and functions using the CX5R consensus active site motif. Like other PTPases, PRL-1 is inhibited by oxidation at its active site Cys, however, disulfide bond formation occurs unusually readily in wild-type PRL-1. Chemical shift assignments are available for oxidized wild type, but numerous, substantial changes are observed in the spectra upon reduction. Because the reduced form is active, we sought to identify a stable mutant that would resist oxidation and be useful for facilitating drug screening and development using NMR-based assays. We present here NMR assignments for a full-length, reduced and active form of PRL-1, PRL-1-C170S-C171S, that is well suited for this purpose.
PRL-1 PTPase Resonance assignments Oxidation Reduction Redox Drug screening
Eghbalnia HR, Bahrami A et al (2005) Probabilistic identification of spin systems and their assignments including coil-helix interference as output (PISTACHIO). J Biomol NMR 32:219–233. doi:10.1007/s10858-005-7944-6CrossRefGoogle Scholar
Goddard TD, Kneller DG (2004) SPARKY 3. University of California, San FranciscoGoogle Scholar
Sun J-P, Wang W-Q et al (2005) Structure and biochemical properties of PRL-1, a phosphatase implicated in cell growth, differentiation, and tumor invasion. Biochemistry 44:12009–12021. doi:10.1021/bi0509191CrossRefGoogle Scholar
Zhou H, Gallina M et al (2003) Letter to the Editor: 1H, 13C, and 15N resonance assignments and secondary structure of the human protein tyrosine phosphatase PRL-2. J Biomol NMR 27:397–398. doi:10.1023/A:1025875618084CrossRefGoogle Scholar